Granisetron is an indazole derivative with antiemetic properties.
As a selective serotonin receptor antagonist, granisetron competitively blocks the action of serotonin at 5-HT3 receptors, resulting in the suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.


Product Name Granisetron Base
CAS Number 109889-09-0
Therapeutic Class Serotonin (5-HT3) receptor antagonist, Antiemetic 
Dosage Form Transdermal Patch, Extended-Release Injection for Subcutaneous use
Availability Commercial
Regulatory Status USDMF